health care effectiveness clinical excellence january 25, 2011

30
Health Care Effectiveness Clinical Excellence January 25, 2011

Upload: irea-meadors

Post on 15-Dec-2015

215 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Health Care Effectiveness Clinical Excellence January 25, 2011

Health Care Effectiveness Clinical Excellence

January 25, 2011

Page 2: Health Care Effectiveness Clinical Excellence January 25, 2011

“We are what we repeatedly do. Excellence, then, is not an act, but

a habit.”

Aristotle

Page 3: Health Care Effectiveness Clinical Excellence January 25, 2011

DiabetesClinical Excellence Award

Page 4: Health Care Effectiveness Clinical Excellence January 25, 2011

Award Recipientcriterion BMC EKL ILH LAK LJC UMC WOM

%cases w/glucose ever < 50 0.05 0.06 0.02 0.03 0.00 0.04 0.07 0.00

%cases w/glucose ever < 70 0.15 0.15 0.11 0.13 0.06 0.12 0.21 0.07

%time 70 < glucose < 180 0.60 0.51 0.60 0.63 0.51 0.60 0.60 0.43

Eye exam in past 15 mos 0.55 0.49 0.62 0.51 0.42 0.62 0.65 0.41

HbA1c 9 mos <= 7% 0.55 0.55 0.47 0.45 0.59 0.58 0.56 0.52

HbA1c in past 9 months 0.80 0.75 0.84 0.81 0.77 0.87 0.81 0.81

LDL 15 mos <= 100 0.55 0.58 0.58 0.63 0.49 0.61 0.62 0.55

LDL test in past 15 mos 0.85 0.84 0.87 0.89 0.81 0.86 0.88 0.85

last BP <= 130/80 0.40 0.34 0.31 0.37 0.31 0.40 0.35 0.40

Leonard J Chabert Medical Center

Page 5: Health Care Effectiveness Clinical Excellence January 25, 2011

DiabetesClinical Lead Award

Page 6: Health Care Effectiveness Clinical Excellence January 25, 2011

Heart Failure Clinical Excellence Award

Page 7: Health Care Effectiveness Clinical Excellence January 25, 2011

Award Recipient

University Medical Center

Leonard J Chabert Medical Center

Lallie Kemp Medical Center

Bogalusa Medical Center

criterion BMC EKL ILH LAK LJC UMC WOMOn ACE/ARB 0.85 0.95 0.87 0.92 0.90 0.96 0.92 0.85On NSAID 0.05 0.00 0.02 0.01 0.01 0.02 0.01 0.04last < 130/80, weighted 0.50 0.50 0.44 0.53 0.50 0.56 0.53 0.43on metop-s, carvedilol, or bisoprolol 0.85 0.85 0.86 0.85 0.85 0.96 0.90 0.85pneumovax ever 0.70 0.92 0.91 0.68 0.76 0.94 0.92 0.90

Page 8: Health Care Effectiveness Clinical Excellence January 25, 2011

Heart Failure Clinical Lead Award

Page 9: Health Care Effectiveness Clinical Excellence January 25, 2011

Asthma Clinical Excellence Award

Page 10: Health Care Effectiveness Clinical Excellence January 25, 2011

Award Recipient

Bogalusa Medical Center

Earl K Long Medical Center

WO Moss Regional Medical Center

criterion BMC EKL ILH LAK LJC UMC WOM% on ICS or ICS/LABA in pers/sevr 0.80 0.92 0.98 0.98 0.91 0.96 0.90 0.80

% with PFT in past 3 yrs 0.70 0.70 0.75 0.65 0.59 0.60 0.51 0.80

Page 11: Health Care Effectiveness Clinical Excellence January 25, 2011

Asthma Clinical Lead Award

Page 12: Health Care Effectiveness Clinical Excellence January 25, 2011

HIV Clinical Excellence Award

Page 13: Health Care Effectiveness Clinical Excellence January 25, 2011

Award Recipient

Leonard J Chabert Medical Center

Interim LSU Public Hospital

WO Moss Regional Medical Center

criterion BMC EKL ILH LAK LJC UMC WOMCD4, CD4 test in past 15 mos 0.90 0.95 0.99 0.99 0.99 0.98 0.99 0.94PCP prophylaxis, CD4 < 200 sustained 0.90 1.00 0.95 0.92 0.80 1.00 0.87 0.94STDs, Chlamydia test in past 15 mos 0.80 0.73 0.77 0.83 0.60 0.93 0.86 0.86STDs, Gonorrhea test in past 15 mos 0.80 0.73 0.77 0.83 0.60 0.93 0.86 0.86viral load test in past year 0.90 0.96 0.98 0.99 0.97 0.98 0.98 0.92

Page 14: Health Care Effectiveness Clinical Excellence January 25, 2011

HIV Clinical Lead Award

Page 15: Health Care Effectiveness Clinical Excellence January 25, 2011

HOP – a TRRRAQSSS Clinic

• Teaching –– 54 Tulane and 44 LSU Fellows to date– 10 Research Fellows – 5 PhD’s from HOP database

• Research: participated in > 400 studies• Revenue: program grants $2,244,000/y

– 1990’s, saved $millions in cost of HIV meds

• Resources: one-stop shop model– on-site subspecialists, HE, social work

• Access: < 24 h to next Phase I appt

Page 16: Health Care Effectiveness Clinical Excellence January 25, 2011

Chronic Kidney Disease Clinical Excellence Award

Page 17: Health Care Effectiveness Clinical Excellence January 25, 2011

Award Recipient

University Medical Center

criterion BMC EKL ILH LAK LJC UMC WOM

ANEMIA, HGB < 10, stage 3conf, stan 0.20 0.04 0.05 0.05 0.04 0.06 0.05 0.05

ANEMIA, HGB < 10, stage 4conf, stan 0.20 0.13 0.24 0.20 0.05 0.21 0.15 0.09

BP, last BP < 130/80, stage 34conf, stan 0.40 0.28 0.35 0.38 0.34 0.39 0.40 0.33

CONF, % confirmed among overdue 0.30 0.43 0.49 0.58 0.61 0.60 0.58 0.40

LIPIDS, HDL > 40, stage 34conf, stan 0.40 0.46 0.45 0.47 0.46 0.42 0.46 0.43

LIPIDS, LDL < 100, stage 34conf, stan 0.65 0.59 0.66 0.60 0.53 0.61 0.66 0.52

LIPIDS, TRIG < 150, stage 34conf, stan 0.60 0.66 0.62 0.67 0.68 0.67 0.70 0.57

PHOS, 2.7 < PHOS < 4.6, stage3conf 0.70 0.90 0.85 0.90 0.93 0.90 0.90 0.91

PHOS, 2.7 < PHOS < 4.6, stage4conf 0.70 0.86 0.87 0.87 0.86 0.84 0.79 1.00

Page 18: Health Care Effectiveness Clinical Excellence January 25, 2011

Chronic Kidney Disease Clinical Lead Award

Page 19: Health Care Effectiveness Clinical Excellence January 25, 2011

Cancer Screening Clinical Excellence Award

Page 20: Health Care Effectiveness Clinical Excellence January 25, 2011

Award Recipient

Bogalusa Medical Center

criterion BMC EKL ILH LAK LJC UMC WOM

Mammogram in past 2 years, age 40-75 0.80 0.82 0.81 0.78 0.85 0.87 0.83 0.88

PSA in past 2 years, age 50-75 0.80 0.89 0.78 0.80 0.87 0.91 0.79 0.85

Pap in 2 yrs (21-29) or 3 yrs (30-69) 0.80 0.80 0.66 0.74 0.44 0.83 0.76 0.65

Scope_10yr OR flexsig_5yr OR FOBT_1yr 0.50 0.53 0.37 0.34 0.48 0.47 0.38 0.33

Page 21: Health Care Effectiveness Clinical Excellence January 25, 2011

Cancer Screening Clinical Lead Award

Page 22: Health Care Effectiveness Clinical Excellence January 25, 2011

Weight ManagementClinical Lead Award

Page 23: Health Care Effectiveness Clinical Excellence January 25, 2011

Tobacco Cessation Clinical Excellence Award

Page 24: Health Care Effectiveness Clinical Excellence January 25, 2011

Award Recipient

Bogalusa Medical Center

Leonard J Chabert Medical Center

Lallie Kemp Medical Center

criterion BMC EKL ILH LAK LJC UMC WOM

% advised 0.90 0.97 0.93 0.96 0.96 0.98 0.96 0.97

% assessed readiness to quit 0.90 0.97 0.93 0.96 0.96 0.98 0.97 0.97% selected assistance among smokers ready to quit 0.70 0.97 0.68 0.66 0.96 0.92 0.78 0.91

screening rate in past 90 days 0.90 0.98 0.86 0.89 0.99 0.93 0.88 0.86

Page 25: Health Care Effectiveness Clinical Excellence January 25, 2011

Tobacco Cessation Clinical Lead Award

Page 26: Health Care Effectiveness Clinical Excellence January 25, 2011

Emergency DepartmentClinical Excellence Award

Page 27: Health Care Effectiveness Clinical Excellence January 25, 2011

Award Recipient

Bogalusa Medical Center

Lallie Kemp Medical Center

BMC EKL ILH LAK LJC UMC WOM

Door to Doctor - Home 67 77 75 74 72 95 108

Doc to Discharge - Home 87 106 115 76 100 72 68

LOS - Home 157 206 233 175 197 195 202

LWOBS 5% 7% 9% 5% 4% 8% 9%

Page 28: Health Care Effectiveness Clinical Excellence January 25, 2011

Emergency DepartmentClinical Lead Award

Page 29: Health Care Effectiveness Clinical Excellence January 25, 2011

HypertensionClinical Lead Award

Page 30: Health Care Effectiveness Clinical Excellence January 25, 2011

Congratulations to All Award Recipients